Skip to main content

JAGLX

ETF
JAGLX · UNKNOWN · 87 holdings
€ 79,46
▲ € 1,51 (1,94%)
Day Range
52-Week Range
Volume
Openen —
50D / 200D Gem.
50D / 200D Gem.

About JAGLX

No description available for this ETF.

Fund Details

Expense Ratio
Inception Date
Prev. Close
€ 77,95
Exchange
UNKNOWN
Currency
USD
Holdings As Of
Apr 10, 2026
Tracked Holdings
88.5%
HHI Score
254,35
Top Sector
Healthcare (90.52231%)

Performance

Low (19,2%) ↗ Recovering
1W
▲ 1,98%
1M
▼ -0,09%
3M
▼ -0,97%
6M
▲ 14,50%
YTD
▼ -0,92%
1Y
▲ 28,07%
3Y
▲ 20,30%

Positive 1W (+1.98%) after negative 1M (-0.09%) — trend may be reversing

Price History

Concentration Risk

39,31% Balanced
Diversified Concentrated

The top 10 holdings represent 39,31% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.

Top Holdings Today

Weighted by position size
LLY
▲ 0,57%
JNJ
▲ 0,60%
AZN
▲ 0,61%
UNH
▲ 0,09%
ABBV
▲ 0,63%
ABT
▼ -0,76%
ARGX
▲ 1,31%
BSX
▼ -2,15%
SNYNF
▼ -1,50%
NVS
▲ 0,68%
Weighted avg. of top holdings ▲ 0,15%

Sector Allocation

Healthcare
90,52%
Manufacturing
3,02%

Top 10 Holdings

39,31% of fund
LLY Eli Lilly & Co.
8,31%
JNJ Johnson & Johnson
5,01%
AZN AstraZeneca PLC
4,22%
UNH UnitedHealth Group Inc.
4,21%
ABBV AbbVie Inc.
3,58%
ABT Abbott Laboratories
3,16%
ARGX Argenx SE
2,82%
BSX Boston Scientific Corporation
2,74%
SNYNF Sanofi SA
2,69%
NVS Novartis AG
2,56%
Other positions
2,48%

All Holdings (87)

Top 10: 39,31% of fund
# Ticker Name Weight Shares Market Value
1 LLY Eli Lilly & Co. 8,31% 497.962 379,95 M
2 JNJ Johnson & Johnson 5,01% 1,24 M 229,16 M
3 AZN AstraZeneca PLC 4,22% 1,26 M 193,09 M
4 UNH UnitedHealth Group Inc. 4,21% 556.891 192,29 M
5 ABBV AbbVie Inc. 3,58% 706.535 163,59 M
6 ABT Abbott Laboratories 3,16% 1,08 M 144,64 M
7 ARGX Argenx SE 2,82% 175.105 129,15 M
8 BSX Boston Scientific Corporation 2,74% 1,29 M 125,49 M
9 SNYNF Sanofi SA 2,69% 1,30 M 122,94 M
10 NVS Novartis AG 2,56% 914.366 117,26 M
Showing top 10 of 87 holdings · Listed: 97,52% · 2,48% in other positions

Related ETFs